IL-7 receptor signaling drives human B-cell progenitor differentiation and expansion
FMP Kaiser, I Janowska, R Menafra, M de Gier… - Blood, 2023 - ashpublications.org
Although absence of interleukin-7 (IL-7) signaling completely abrogates T and B
lymphopoiesis in mice, patients with severe combined immunodeficiency caused by …
lymphopoiesis in mice, patients with severe combined immunodeficiency caused by …
Cell circuits between leukemic cells and mesenchymal stem cells block lymphopoiesis by activating lymphotoxin beta receptor signaling
Acute lymphoblastic and myeloblastic leukemias (ALL and AML) have been known to modify
the bone marrow microenvironment and disrupt non-malignant hematopoiesis. However, the …
the bone marrow microenvironment and disrupt non-malignant hematopoiesis. However, the …
[HTML][HTML] Angelica sinensis polysaccharides ameliorated 5-Fluorouracil-induced damage of early B cell progenitors by alleviating oxidative stress of IL-7 producing …
H Xiao, Y Wang, Z Wang, B Wang, L Hu, J Hou… - Biomedicine & …, 2023 - Elsevier
B-lymphocytopenia among myelosuppression is the most intractable side effect of
chemotherapy. Here, we investigated ways to alleviate 5-fluorouracil-caused stress …
chemotherapy. Here, we investigated ways to alleviate 5-fluorouracil-caused stress …
间充质干细胞治疗自身免疫性肝病的临床研究进展.
史婉婉， 钱建丹， 王贵强 - Journal of Clinical Hepatology …, 2023 - search.ebscohost.com
自身免疫性肝病因治疗选择和方式比较局限, 因此迫切需要寻求新的治疗方法.
间充质干细胞(MSC) 作为干细胞治疗最常见的细胞来源, 在调节先天和适应性免疫反应中发挥着 …
间充质干细胞(MSC) 作为干细胞治疗最常见的细胞来源, 在调节先天和适应性免疫反应中发挥着 …
Clinical research advances in mesenchymal stem cells for the treatment of autoimmune liver diseases
SHI Wanwan, Q Jiandan - 临床肝胆病杂志, 2023 - lcgdbzz.org
Due to limited options and modalities for the etiological treatment of autoimmune liver
diseases, it is urgent to seek new therapeutic methods for liver autoimmune diseases. As the …
diseases, it is urgent to seek new therapeutic methods for liver autoimmune diseases. As the …